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Background: Asymmetrical distribution of 
specific phospholipids between the two leaflets of 
biological membranes is generated and maintained 
by transporters. 
Results: A mutation in murine Atp11c results in 
altered morphology and shortened lifespan of 
erythrocytes.  
Conclusion: Phospholipid transport by ATP11C 
maintains phospholipid asymmetry in erythrocytes. 
Significance: Defects in phospholipid transport 
across the cell membrane can lead to anemia. 
ABSTRACT 
Transmembrane lipid transporters are 
believed to establish and maintain the 
phospholipid asymmetry in biological 
membranes; however, little is known about the 
in vivo function of the specific transporters 
involved. Here we report that developing 
erythrocytes from mice lacking the putative 
phosphatidylserine (PS) flippase, ATP11C 
showed a lower rate of PS translocation in vitro 
compared to erythrocytes from wild-type 
littermates. Furthermore, the mutant mice had 
an elevated percentage of PS-exposing mature 
erythrocytes in the periphery. While 
erythrocyte development in ATP11C-deficient 
mice was normal, the mature erythrocytes had 
an abnormal shape (stomatocytosis), and the 
lifespan of mature erythrocytes was shortened 
relative to that in littermate controls resulting 
in anemia in the mutant mice. Thus, our 
findings uncover an essential role for ATP11C 
in erythrocyte morphology and survival and 
provide a new candidate for the rare inherited 
blood disorder stomatocytosis with 
uncompensated anemia. 
Mammalian erythrocytes are unique amongst 
eukaryotic cells in that they lack nuclei, 
cytoplasmic structures and organelles. Because of 
this, the structural and functional properties of 
erythrocytes are closely associated with their 
plasma membranes (1). The erythrocyte plasma 
"This research was originally published in the Journal of Biological Chemistry. Yabas, Coupland, Cromer, Winterberg, Teoh, D'Rozario, Kirk, Broer, 
Parish & Enders. 2014. Vol 289:19531-19537. © the American Society for Biochemistry and Molecular Biology"
ATP11C Affects Red Cell Lifespan and Morphology	  
membrane consists of a lipid bilayer with an 
asymmetrical distribution of specific 
phospholipids between the two leaflets of the 
bilayer (2). While phosphatidylcholine and 
sphingomyelin are concentrated predominantly in 
the outer monolayer of the erythrocyte membrane, 
phosphatidylserine (PS) and 
phosphatidylethanolamine (PE) are mainly 
confined to the cytoplasmic leaflet (2). The 
generation and maintenance of this asymmetric 
structure is essential for the function and survival 
of all cells including erythrocytes (1,2). The 
concentration of PS in the cytofacial leaflet of the 
plasma membrane provides important docking 
sites for a variety of signaling molecules (3) and, 
in particular in erythrocytes, plays an essential role 
in the modulation of the mechanical stability of the 
membrane, through an interaction with the skeletal 
protein spectrin (4,5). PS exposure on the surface 
of erythrocytes acts as an “eat me” signal to 
phagocytes and also can lead to adherence of 
erythrocytes to the vascular endothelium and 
activation of surface-dependent plasma blood 
clotting factors (2), as well as contributing to the 
anemia observed in a wide variety of blood 
disorders, including sickle cell anemia and 
thalassemia (6-10). Three different groups of 
enzymes are involved in establishing and 
maintaining phospholipid asymmetry, namely 
flippases, floppases and scramblases (11,12).  
Erythrocytes have served as a model system to 
characterize phospholipid movement across 
bilayers. Considerable attempts have been made to 
isolate and identify the major aminophospholipid 
flippases from red blood cells and other 
membranes (13-17). The biochemical 
characterization suggests that the erythrocyte 
flippase is a Mg2+-dependent, vanadate-sensitive 
ATPase (13). Studies in yeast suggest that 
members of the P4-type ATPase family serve as 
“flippases”, selectively translocating PS, and to a 
lesser extent PE, into the cytoplasmic leaflet of 
cell membranes (11,12,18). Although there are 15 
members of the P4-type ATPase family in mice 
(14 members in humans) (12), their biological 
functions are largely unknown (19), and so far 
only a few flippases have been linked to biological 
functions in mammalians. Among these, mutations 
in the gene encoding ATP8A2 in human and mice 
have been shown to cause neurological disorders 
(20-22). In addition, ATP8B1 and ATP11C have 
been implicated bile secretion in mice, which 
involves translocation of phospholipids (23,24). 
Furthermore, we and others recently discovered 
that ATP11C, which is encoded on the X-
chromosome in humans and mice, is required for 
the development of adult B cells (25,26). With 
regard to erythrocytes, ATP8A1 has been 
proposed to be the molecular correlate of the 
erythrocyte flippase activity. The protein was 
detected in the plasma membrane of mature 
erythrocytes and flippase activity was 
demonstrated upon expression in yeast (27). 
However, the biochemical characteristics of 
ATP8A1 are consistent with the flippase from 
chromaffine granules, which is different from the 
major flippase activity observed in erythrocytes 
(28). Consistently, erythrocytes from Atp8a1-/- 
animals exhibit no increased PS exposure on their 
surface, most likely due to expression of other 
aminophospholipid flippases (29). In our initial 
study on the role of ATP11C in B cells we also 
noted a significant reduction in the number of total 
erythrocytes in the blood of ATP11C mutant mice 
(25). Here we investigate this anemia and 
demonstrate that the mutant erythrocytes have a 
shortened lifespan and an abnormal shape 
manifesting itself as a pronounced stomatocytosis. 
Impaired flippase activity during erythropoiesis 
was confirmed in the mutant mice and circulating 
mutant erythrocytes were shown to have elevated 
surface-exposure of PS that increased with the age 
of the cells. 
 
EXPERIMENTAL PROCEDURES 
Mice–The Ambrosius mouse strain with an X-
linked N-ethyl-N-nitrosourea-induced point 
mutation in Atp11c has been described previously 
(25). All animal procedures were approved by the 
Australian National University Animal Ethics and 
Experimentation Committee. 
Analysis of Hematologic Parameters–An 
ADVIA 2120 Hematology System (Siemens 
Healthcare Diagnostics) was used for the analysis 
of blood parameters. 
Clinical Chemistry–Serum concentrations of 
iron parameters were assayed by automated 
procedures in the Department of Pathology, The 
Canberra Hospital. 
Flow Cytometry–Procedures for surface and 
Annexin-V staining have been described 
previously (25). For flow cytometric analysis the 
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following antibodies were used: CD71-Biotin or -
PE (Clone C2), Ter119-FITC or -PE-Cy7, CD44-
APC (Clone IM7), Streptavidin-APC (all from 
BD) and Annexin-V-Pacific Blue (Biolegend). 
In vivo Erythrocyte Lifespan Analysis–In vivo 
lifespan measurements using carboxyfluorescein 
diacetate succinimidyl ester (CFSE), in 
conjunction with mathematical modeling were 
performed as described previously (30). 
Flippase Assay–Flippase activity was assessed 
as described previously (25) with the modification 
that 16:0-06:0-NBD-PS (Avanti Polar Lipids) was 
used in place of 16:0-12:0-NBD-PS and all 
incubations were performed at 15 °C instead of 
37 °C to avoid non-specific uptake of the PS 
analogue. 
Cation Measurement–Intra- and extracellular 
Na+ and K+ levels were determined using Ultra 
High Pressure Liquid Chromatography (UHPLC; 
Dionex) linked to a Charged Aerosol Detector 
(CAD; Dionex) as described elsewhere (31). In 
brief, 10 µL-heparinized blood was separated by 
centrifugation into erythrocyte and plasma 
fractions. The erythrocytes were washed (x1) with 
a 250 mM MgSO4 solution to replace extracellular 
Na+ and K+. The resulting cell pellet, and 1 uL of 
the plasma, were added to 200 and 100 µL, 
respectively, of 40/60 v/v 20 mM ammonium 
sulphate pH 5/acetonitrile, to precipitate proteins. 
The samples were centrifuged and 10 µL aliquots 
of the resulting supernatant solutions were 
subjected to the HPLC analysis. 
Scanning Electron Microscopy (SEM) 
Analysis–Cells attached to coverslips were fixed 
with 2% v/v glutaraldehyde in 0.1 M sodium 
cacodylate overnight at 4 oC and post-fixed with 
1% w/v osmium tetroxide for 1.5 hours at room 
temperature. The samples were dehydrated using a 
graded ethanol series, then critical point dried, 
mounted on aluminium stubs, and sputter-coated 
with gold prior to imaging. Images were taken 
using a Zeiss Ultraplus FESEM. 
Osmotic Fragility Test–Peripheral blood from 
wild-type and ATP11C-deficient mice was diluted 
to an approximate hematocrit of 10% with PBS 
followed by a further 1 in 10 dilution in NaCl 
solutions of varying osmolarity (0.1%-0.8% w/v 
NaCl in H2O). After incubation for 30 minutes at 
room temperature, samples were centrifuged and 
the absorbance of the supernatant solutions 
measured at 540 nm (A540) using a microplate 
reader (ThermoMax; Molecular Devices). 
Percentage hemolysis of the cells in each solution 
was calculated based on the A540 value relative to 
that obtained for cells suspended (and thereby 
lysed) in H2O.  
Statistical Analysis–For comparison of only 
two groups, the two-tailed Student’s t-test was 
used. When multiple experimental groups were 
being compared, One-Way analysis of variance 
(ANOVA), followed by pair-wise comparison 
with a Bonferroni post-test were used. All 
statistical analyses were performed using 
GraphPad Prism Software. 
 
RESULTS and DISCUSSION 
ATP11C Deficiency in Mice Results in 
Anemia–To extend our previous finding of anemia 
in ATP11C-deficient mice (25), we analyzed 
different hematologic parameters in the blood of 
mutant male mice and their control littermates. 
Mutant mice showed an approximate 25% 
reduction in the number of erythrocytes compared 
to wild-type littermates among all age groups (Fig. 
1A). While the relative proportion of immature 
erythrocytes (reticulocytes) was increased from 
2.85 ± 0.2% to 4.24 ± 0.2% in the blood of 6-8 
weeks old ATP11C mutant animals, the absolute 
number of reticulocytes was not significantly 
increased (Fig. 1A). Interestingly, erythrocytes 
from mutant mice were larger with a higher mean 
corpuscular volume (MCV) than controls among 
all age groups (Fig. 1A). Similar results were 
found in homozygous mutant female mice (data 
not shown). In contrast, Atp11camb/+ heterozygous 
female mice had a normal erythrocyte count in the 
peripheral blood (data not shown). These results 
reveal that ATP11C deficiency in mice causes 
anemia, and suggest that ATP11C plays a 
significant role in the development and/or survival 
of erythrocytes.  
Normal Erythropoiesis, but Reduced 
Erythrocyte Lifespan in ATP11C-deficient Mice–
To assess if ATP11C is required for erythropoiesis, 
we examined the early stages of erythroid 
development in the bone marrow and spleen. 
Stepwise analysis of different stages of 
erythroblast differentiation based on expression of 
the surface marker CD44 and forward scatter 
profile (32) showed that ATP11C-deficient mice 
have essentially normal erythropoiesis in the bone 
marrow and spleen (Fig. 1, B and C). These results 
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indicate that animals deficient for ATP11C have 
no block in erythrocyte development.  
Thus we next focused on the lifespan of 
mature erythrocytes to explain the observed 
anemia in ATP11C-deficient animals. The lifespan 
of erythrocytes was investigated using dilution of 
a fluorescent label (CFSE) in vivo and 
mathematical modeling previously described (30). 
Erythrocytes from ATP11C-deficient animals 
exhibited reduced survival compared to cells from 
their control littermates as determined by the 
percentage of CFSE-labeled erythrocytes in the 
blood (Fig. 1D). Erythrocyte survival data showed 
an average lifespan of 25.2 ± 3.5 days in mutant 
animals, compared to 38.7 ± 3.6 days in control 
littermates (presented as means ± S.E.M., p < 
0.05) (Fig. 1E). These data indicate that ATP11C 
plays an important role in the survival of 
erythrocytes. 
ATP11C-deficient Erythrocytes Form 
Stomatocytes–The composition and asymmetric 
distribution of phospholipids in the cell membrane 
is essential for maintaining the normal biconcave 
shape of erythrocytes (5). Morphological studies 
of erythrocytes from the blood of ATP11C-
deficient and littermate control mice were 
performed using scanning electron microcopy. As 
shown in Fig. 2A the majority of mutant 
erythrocytes showed a distinct change in 
morphology known as stomatocytosis (Fig. 2A). 
These results were confirmed with peripheral 
blood smears (Fig. 2B). Consistent with an 
increased mean corpuscular volume, flow 
cytometry analysis revealed that erythrocytes in 
the blood and spleen from ATP11C-deficient 
animals were significantly larger than erythrocytes 
from control animals as determined by an increase 
in their forward scatter profile (Fig. 2C). This 
increased size was first apparent in mature 
erythrocytes in the bone marrow, but also in 
erythrocyte precursors in the spleen (Fig. 1, B and 
C).  
The effect of the mutation on osmotic fragility 
was assessed by incubating erythrocytes from 
ATP11C-deficient mice and wild-type littermates in 
solutions of varying osmolarity, and measuring the 
extent of hemolysis. Erythrocytes from ATP11C-
deficient mice displayed a normal hemolysis profile, 
suggesting that their surface-to-volume ratio and cell 
hydration is comparable to that in erythrocytes from 
wild-type mice (Fig. 2D). 
No Effect of ATP11C on Na+ and K+ 
Homeostasis–Stomatocytosis has been associated 
with altered cation transport across the erythrocyte 
membrane, and, consequentially, perturbation of 
erythrocyte Na+ and K+ homeostasis (33). In some 
cases the cation transport abnormality is enhanced 
upon reduction of the temperature to which the 
cells are exposed (34). Comparisons of the ratio of 
Na+ to K+ in erythrocytes from ATP11C-deficient 
mice with those from control mice, using ion 
chromatography, revealed there to be no 
difference between the two groups (Fig. 2E). 
Measurement of the plasma K+ concentration in 
blood samples 30 min after blood collection and 
after incubation for a further 1 and 3 hours at room 
temperature (in order to enhance any temperature-
dependent K+ leak that might be present) revealed 
no significant difference in the plasma K+ 
concentrations in ATP11C-deficient mice and 
wild-type mice (Fig. 2F). ATP11C deficiency 
apparently therefore has no significant effect on 
erythrocyte Na+ and K+ homeostasis.  
Hereditary stomatocytosis in humans can 
cause iron overload (33). We therefore measured 
serum iron and transferrin in 8-10 and 18-20 week 
old ATP11C-deficient mice and their wild-type 
littermates. Serum iron and transferrin levels were 
comparable between mutant and wild-type animals 
and between both age groups (data not shown) 
thus excluding iron overload as a feature of the 
stomatocytosis seen in these mice. 
Lower PS Flippase Activity in Erythroblasts 
from ATP11C-deficient Mice–We previously 
demonstrated that developing B-lymphocytes in 
ATP11C-deficient mice display impaired PS 
internalization relative to B-lymphocytes in wild-
type mice (25). To test if there is a similar defect 
in developing or mature erythrocytes we 
performed an in vitro flippase activity assay using 
a fluorescent PS analogue (NBD-PS). We first 
tested flippase activity in the different erythroid 
stages (Proerythroblasts, Basophilic erythroblasts, 
Polychromatic erythroblasts, Orthochromatic 
erythroblasts and reticulocytes, and mature red blood 
cells); gates as regions I, II, III, IV and V 
respectively in Fig. 1, B and C in the bone marrow 
and spleen, separated on the basis of their CD44 
and forward scatter profiles (32). Erythroid 
precursors (R I – R III) from wild-type mice took 
up NBD-PS rapidly whereas orthochromatic 
erythroblasts and reticulocytes as well as mature 
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erythrocytes (R IV and R V respectively) showed 
a significantly reduced overall NBD-PS uptake 
(Fig. 3, A and B), indicating that flippase activity 
decreases with erythrocyte maturity. At all stages, 
NBD-PS uptake approached equilibrium by 30 
min (Fig. 3, A and B). In comparison, the uptake of 
NBD-PS by ATP11C mutant erythroid precursors 
(R I – R III) was significantly slower (Fig. 3, A 
and B). The difference in NBD-PS internalization 
between wild-type and ATP11C-deficient cells 
was less marked in the more mature forms (R IV – 
R V) (Fig. 3, A and B). Similarly, there was a very 
low uptake of NBD-PS in erythrocytes from 
peripheral blood of wild-type and ATP11C-
deficient mice with only a minimal reduction in 
mutant erythrocytes (data not shown).  
Increased PS Exposure on the Surface of 
ATP11C-deficient Erythrocytes–The appearance 
of PS in the exoplasmic leaflet of erythrocyte 
membranes serves as an “eat-me” signal for the 
recognition and clearance of erythrocytes by 
phagocytes (35,36). To test if the defective 
flippase activity in mutant animals results in 
increased surface accumulation of PS, erythrocytes 
from the peripheral blood were stained with 
Annexin-V which binds to PS in the exoplasmic 
leaflet (37). The percentage of Annexin-V+ 
erythrocytes in the blood of ATP11C-deficient 
mice was 17-fold higher than in control littermates 
in which there were virtually no Annexin-V+ 
erythrocytes (4.28 ± 0.50% vs. 0.25 ± 0.05%, p < 
0.0001) (Fig. 3C). We next determined the extent 
of Annexin-V binding as a function of erythrocyte 
age using in vivo CFSE labeling. At all ages tested 
(newly generated to 50 days of age) there was 
virtually no Annexin-V binding by wild-type 
erythrocytes (Fig. 3D). However, as ATP11C-
deficient erythrocytes aged, there was a gradual 
increase in the number of Annexin-V binding from 
4.3% of newly formed erythrocytes (CFSE-) to 
more than 20% of erythrocytes aged ≥ 39 days 
(CFSE+) (Fig. 3D). In agreement with the 
accumulation of PS on aged erythrocytes we also 
found a greater than two-fold increase in the 
frequency of Annexin-V+ erythrocytes in the 
spleen of mutant mice compared to their control 
littermates (31 ± 2% vs. 14 ± 1%, p < 0.0001) (Fig. 
3E). In contrast, no difference in Annexin-V 
staining was observed on erythroblasts in the bone 
marrow of wild-type and ATP11C-deficient mice 
(data not shown). These data demonstrate that 
ATP11C-deficient erythrocytes accumulate PS on 
their surface in the peripheral circulation. 
Significantly reduced in vitro uptake of the 
fluorescently labeled PS analogue NBD-PS by 
mutant erythroblasts but not by mature 
erythrocytes is consistent with the fact that the 
protein is expressed predominantly during 
erythropoiesis (38). Alternatively, it may also 
indicate that in ATP11C-deficient erythrocytes the 
reduced rate of PS flipping during the early 
developmental stages may have a lasting change 
on the membrane composition, resulting in 
reduced erythrocyte deformability, increased 
intravascular damage and hence PS exposure.  
Beside ATP11C, several other P4-type 
ATPases are expressed during erythropoiesis, with 
ATP8A1 and ATP11B being particularly 
prominent in primitive, fetal and adult 
erythroblasts (38). Interestingly, Atp8a1-/- mice 
exhibited no erythrocyte phenotype, which can be 
explained by the compensatory expression of 
ATP8A2 in Atp8a1-/- erythrocytes (29). The 
observation of reduced, but not absent PS 
translocation in ATP11C-deficient erythroblasts 
suggests that other translocases may still be 
present in mutant erythroblasts. In addition to their 
effect on phospholipid translocation P4-type 
ATPases have also been linked to vesicle 
trafficking (12,18). This raises the possibility that 
loss of ATP11C activity may result in defects in 
membrane or protein trafficking, including 
trafficking of other translocases like ATP8A1 that 
are expressed in erythrocytes. Furthermore, lack of 
ATP11C may lead to a compensatory 
overexpression of ATP8A1 and other P4-type 
ATPases that partially compensates for the lack of 
ATP11C. Differentiation between a direct or more 
indirect effect of ATP11C defects on PS 
translocation will require further studies, including 
the development of better antibodies against all 
P4-type ATPases that go beyond the scope of this 
study. 
The abnormal stomatocyte shape of 
erythrocytes in ATP11C mutant mice has been 
found to be independent of cation leaks or 
hydration status, and suggests that an alternative 
mechanism is responsible for the stomatocytosis in 
these mice. One possibility is a mechanism similar 
to that responsible for Mediterranean 
stomatocytosis (39), in which a lack of control 
over sterol absorption and excretion leads to 
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changes in the plasma lipid composition and 
presumably the membrane lipid composition of 
circulating cells. Alterations in the relative lipid 
composition of the erythrocyte membrane can lead 
to an expansion or contraction of either the inner 
or outer leaflet, resulting in altered erythrocyte 
shape (40-42). In addition, reduced accumulation 
of PS at the cytofacial leaflet is predicted to 
interfere with the interaction between skeletal 
proteins and the membrane (4,5). It is plausible, 
therefore, that a disturbance in these interactions 
underlies the observed formation of stomatocytes 
in ATP11C mutant mice.  
In conclusion, the results presented in this 
study reveal an important functional role for 
ATP11C in erythrocyte biology, and raise the 
question of whether mutations in ATP11C serve as 
a previously unclassified cause of stomatocytosis 
in humans. Whether the observed blood 
phenotypes in ATP11C-deficient mice occur as a 
result of changes to the erythrocyte membrane 
composition and/or through changes to the 
interaction between erythrocytes and other cells, 
for example splenic macrophages, will be an 
important area for future studies.  
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FIGURE LEGENDS 
 
FIGURE 1. Anemia in mice with a point mutation in Atp11c due to a reduced lifespan despite 
normal erythropoiesis. A, graphs show the number of erythrocytes, hemoglobin, hematocrit, the number 
of reticulocytes, mean corpuscular hemoglobin (MCH) and mean corpuscular volume (MCV) in the blood 
of Atp11c+/0 (WT, open circle) and Atp11camb/0 (Amb, black filled circle) animals of the indicated age 
groups. The symbols represent mean ± S.E.M. with four to eight mice per genotype in each age group. B 
and C, representative flow cytometric contour plots of CD44 and forward scatter (FSC) profiles in the 
bone marrow (B) and spleen (C) of Atp11c+/0 (WT) and Atp11camb/0 (Amb) animals. The plots are pre-
gated on CD71+ and Ter119+ erythrocytes. Bar graphs represent mean ± S.E.M. of the percentage of cells 
in the outlined areas in the flow cytometric plots. Data are representative of at least five independent 
experiments with one to four mice per genotype in each. D, graph shows mean ± S.E.M. of the percentage 
of CFSE-labeled erythrocytes in the blood of Atp11c+/0 (WT, open circle) and Atp11camb/0 (Amb, black 
filled circle) mice after in vivo labeling. E, average erythrocyte lifespan calculated by lognormal modeling 
from the data presented in (D). Bar graph represents mean ± S.E.M. of the average survival of 
erythrocytes. Data are representative of two independent experiments with four to five mice per genotype 
in each. Statistical significance was calculated using One-Way ANOVA analysis, followed by the 
ATP11C Affects Red Cell Lifespan and Morphology	  
Bonferroni post-test, with the p values comparing each age pair of groups shown on the plots (A) or the 
two-tailed Student’s t-test (B-E). ns, not significant; #, p < 0.0001; ***, p < 0.001; **, p < 0.01; *, p < 0.05. 
 
FIGURE 2. Abnormally shaped erythrocytes in the periphery of ATP11C-deficient mice. A, 
scanning electron microscopic analysis of erythrocytes from the blood of Atp11c+/0 (WT) and Atp11camb/0 
(Amb) animals. B, peripheral blood smears from Atp11c+/0 (WT) and Atp11camb/0 (Amb) animals. C, 
representative overlay histograms of forward scatter (FSC) profile in Ter119+ erythrocytes from the bone 
marrow, spleen and blood of Atp11c+/0 (WT, shaded grey) and Atp11camb/0 (Amb, black line) animals. 
Data are representative of three independent experiments with four to six mice per genotype in each. D, 
osmotic fragility of erythrocytes from Atp11c+/0 (WT, open circle) and Atp11camb/0 (Amb, black filled 
circle) mice. The symbols represent mean ± S.E.M. of the percentage of hemolysis. Data are 
representative of three independent experiments with four to five mice per genotype in each. E, ratio of 
intra-erythrocytic Na+ and K+ of Atp11c+/0 (WT) and Atp11camb/0 (Amb) animals analyzed by high-
performance liquid chromatography within 30 min of blood collection (0.5 h) and after resting at room 
temperature for 1.5 and 3.5 hours. Bar graph represents mean ± S.E.M. of the ratio of intra-erythrocytic 
Na+ and K+ content. F, HPLC measurement of K+ in the plasma of Atp11c+/0 (WT) and Atp11camb/0 (Amb) 
animals within 30 min of blood collection (0.5 h) and after resting at room temperature for 1.5 and 3.5 h. 
Bar graph represents mean ± S.E.M. of the plasma K+ content. Data are representative of two independent 
experiments with four to five mice per genotype in each. 
 
 
 
FIGURE 3. Reduced flippase activity in mutant erythroblasts and increased PS exposure in mature 
erythrocytes from ATP11C-deficient animals. A and B, graphs show C6-NBD-PS uptake after 0, 1, 3, 5, 
10, 20 and 30 min incubation in Proerythroblasts, Basophilic erythroblasts, Polychromatic erythroblasts, 
Orthochromatic erythroblasts and reticulocytes and mature red blood cells (regions I, II, III, IV and V 
respectively, gated as in Fig. 1, B and C) in the bone marrow (A) and spleen (B) from Atp11c+/0 (WT, open 
circle) and Atp11camb/0 (Amb, black filled circle) mice. Graphs represent mean ± S.E.M. of the percentage of 
C6-NBD-PS uptake relative to wild-type region II at 30 min at which the highest rate of PS internalization is 
observed. Data are pooled from five independent experiments with one mouse per genotype in each. C, 
representative overlay histogram of Annexin-V staining in Ter119+ erythrocytes in the blood of Atp11c+/0 
(WT, shaded grey) and Atp11camb/0 (Amb, black line) animals. Bar graphs represent mean ± S.E.M. of the 
percentage of Annexin-V+ cells in Ter119+ erythrocytes. Data are representative of at least three 
independent experiments with four to six mice per genotype in each. D, graph shows mean ± S.E.M. of 
the percentage of Annexin-V+ cells among circulating CFSE- or CFSE+ erythrocytes in the blood of 
Atp11c+/0 (WT) and Atp11camb/0 (Amb) mice after in vivo labeling. E, representative overlay histogram of 
Annexin-V staining in Ter119+ erythrocytes in the spleen of Atp11c+/0 (WT, shaded grey) and Atp11camb/0 
(Amb, black line) animals. Bar graphs represent mean ± S.E.M. of the percentage of Annexin-V+ cells in 
Ter119+ erythrocytes. Data are representative of at least three independent experiments with four to six 
mice per genotype in each. Statistical significance was calculated using the two-tailed Student’s t-test. #, p 
< 0.0001. 
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